Oct 2026
A-234 Protein S Activity Assay Reagent Unaffected by DOACs
The use of direct oral anticoagulants (DOACs) for the prevention and treatment of venous thromboembolism (VTE) has been steadily increasing, establishing DOACs as a viable alternative to warfarin. However, it has been reported that DOACs can interfere with coagulation tests that rely on clotting assays. This inte...
Kohki Kido, Jin Xiuri, Mikako Mori et al.
· Clinical Chemistry · 0 citations